Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore · Delayed Price · Currency is SGD 0.0320
-0.0010 (-3.03%)
At close: Jun 11, 2026
SGXC:9G2 Revenue
Singapore Institute of Advanced Medicine Holdings had revenue of 3.94M SGD in the quarter ending March 31, 2026, a decrease of -1.91%. This brings the company's revenue in the last twelve months to 16.16M, up 0.80% year-over-year. In the fiscal year ending June 30, 2025, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.71M, down -5.63%.
Revenue (ttm)
16.16M
Revenue Growth
+0.80%
P/S Ratio
2.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
39.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | 12.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kin Global | 60.15M |
| Mencast Holdings | 46.34M |
| Mooreast Holdings | 38.33M |
| Dezign Format Group | 33.10M |
| Aedge Group | 32.06M |
| Samurai 2K Aerosol | 26.17M |
| Jiutian Chemical Group | 20.18M |
| Sitra Holdings (International) | 15.38M |